美国 · 平台与数据 · Yahoo Finance
Arcus Biosciences (RCUS) Stock Looks Stretched As Casdatifan Trial Data Impresses
Arcus Biosciences has pulled back sharply in recent weeks, even though investors are still digesting fresh trial data and a sizeable equity raise. For anyone looking at the stock…
在 Yahoo Finance 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (finance.yahoo.com)
